https://doi.org/10.4081/ecj.2025.13407
Association between “D-dimeritis” in the emergency department and COVID-19 hospital burden
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 10 March 2025
This study analyzed D-dimer tests requested by the two emergency departments of the University Hospital Trust of Verona during the Coronavirus disease 2019 (COVID-19) pandemic. Our findings show that the aggregate monthly number of D-dimer test requests from both emergency departments increased significantly (+39%) in 2021 compared to 2019, followed by a steady decline until 2024, when the aggregate monthly test requests were nearly threefold lower than before the pandemic. A strong association was observed between monthly D-dimer test requests and ICU admissions for COVID-19 in Verona (r=0.90; p=0.037), whereas no significant correlation was found with COVID-19 positive cases (r=0.11; p=0.855) or COVID-19 hospitalizations (r=0.70; p=0.118) in Verona. These results suggest that the heightened severity of COVID-19 cases during the early pandemic phase was a key driver of increased D-dimer test requests, while the subsequent decline may reflect reduced disease burden, improved test appropriateness through enhanced healthcare staff education, and a better understanding of COVID-19 pathophysiology.
Downloads
Wauthier L, Favresse J, Hardy M, et al. D-dimer testing: A narrative review. Adv Clin Chem 2023;114:151-223.
Zhan H, Chen H, Liu C, et al. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clin Appl Thromb Hemost 2021;27:10760296211010976.
Lippi G, Mattiuzzi C, Favaloro EJ. Diagnostic value of D-dimer in differentiating multisystem inflammatory syndrome in Children (MIS-C) from Kawasaki disease: systematic literature review and meta-analysis. Diagnosis (Berl) 2024;11:231-4.
Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022;22:639-49.
Thachil J, Favaloro EJ, Lippi G. D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. Semin Thromb Hemost 2022;48:672-9.
Favaloro EJ, Lay M, Mohammed S, et al. Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing. Pathology 2023;55:155-9.
Lippi G, Perilli V. Has "D-Dimeritis" Worsened during the Coronavirus Disease 2019 Pandemic? Semin Thromb Hemost 2023;49:565-7.
Mattiuzzi C, Lippi G. Timeline analysis of clinical severity of COVID-19 in the general population. Eur J Intern Med 2023;110:97-8.
Lippi G, Mullier F, Favaloro EJ. D-dimer: old dogmas, new (COVID-19) tricks. Clin Chem Lab Med 2022;61:841-50.
Onorato D, Negrini D, Lippi G. Laboratory medicine and COVID-19 pandemic impact effects of SARS-CoV-2 pandemic on laboratory medicine. Riv Ital Med Lab 2024;20:24-30.
Lippi G, Cervellin G, Casagranda I, et al. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med 2014;52:621-8.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
